Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duke PAD Protocol in Ventilated CICU Patients
NCT02903407Phase 4Terminated
- Sponsor
- Duke University
- Start
- Sep 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propofol injection (veterinary) and dexmedetomidine in critical illness, sponsored by Duke University. Primary endpoint: Intensive Care Unit Length of Stay at 1 month. Started Sep 2017; status: terminated.
02
Drugs
propofol injection (veterinary)dexmedetomidine
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT02903407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02903407.